Abstract
Antidepressant prescribing patterns have changed globally over the past few years, with conventional drugs including tricyclic antidepressants and monoamine oxidase inhibitors being replaced by selective serotonin reuptake inhibitors (SSRIs) and novel antidepressants. The objective of this study was to assess antidepressant utilization in Iran from 2006 to 2013 and to show Iran’s situation in antidepressant consumption compared with other countries. A cross-sectional study was undertaken using prescription claims data from Iranian insurance agencies. In addition, total antidepressant sales data were obtained from the databank of the national regulatory authority. Medicines were classified according to the Anatomic Therapeutic Chemical (ATC-2012 edition) System. The Organisation for Economic Co-operation and Development data were used to compare national results from Iran with other countries. Antidepressant sales were four-fold higher than those of prescribed antidepressants [24 defined daily doses (DDD)/1000 inhabitants/day were sold whereas 6 DDD/1000 inhabitants/day were prescribed in 2013]. The trend in antidepressant prescriptions and consumption showed increasing use of SSRIs (N06AB). Nortriptyline, fluoxetine, and citalopram accounted for more than 60% of all prescriptions each year. The type of adverse reactions with new expensive antidepressants may seem convincing for the growing tendency toward using these medicines, but considering their high costs, health policymakers have to be aware of the risk of overprescription of newer antidepressant. Drivers of over-the-counter purchase of antidepressants need to be explored.
Article PDF
Avoid common mistakes on your manuscript.
References
Marcus M, Yasamy MT, van Ommeren M, Chisholm D, Saxena S. Depression. A global public health concern. Depression: A Global Crisis. World Federation for Mental Health, Vol. 1, Occoquan, VA; 2012; p. 6–8.
Duthey B. Priority medicines for Europe and the world: “a public health approach to innovation”. Geneva: WHO Background Paper, 2013; p. 6.
Noorbala AA, Bagheri Yazdi SA, Yasamy MT, Mohammad K. Mental health survey of the adult population in Iran. Br J Psychiatry 2004;184;70–3.
Mohammadi MR, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, Pouretemad HR, et al. An epidemiological survey of psychiatric disorders in Iran. Clin Pract Epidemiol Ment Health 2005;1;16.
Naghavi M, Abolhassani F, Pourmalek F, Lakeh MM, Jafari N, Vaseghi S, et al. The burden of disease and injury in Iran 2003. Popul Health Metr 2009;7;9.
Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA. Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry 1998;55;310–16.
Pratt LA, Brody DJ, Gu Q. Antidepressant use in persons aged 12 and over: United States, 2005–2008. NCHS Data Brief, 2011;76;1–8.
Uchida N, Chong MY, Tan CH, Nagai H, Tanaka M, Lee MS, et al. International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: Analysis of 1898 cases from China, Japan, Korea, Singapore and Taiwan. Psychiatry Clin Neurosci 2007;61;522–8.
Guaiana G, Andretta M, Corbari L, Mirandola M, Sorio A, D’Avanzo B, et al. Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. J Clin Psychiatry 2005;66;750–5.
Lawrenson RA, Tyrer F, Newson RB, Farmer RD. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord 2000;59;149–57.
Martín-Agueda B, López-Muñoz F, Rubio G, Guerra JA, Silva A, Álamo C. Management of depression in primary care: a survey of general practitioners in Spain. Gen Hosp Psychiatry 2005;27;305–12.
Olié J P, Elomari F, Spadone C, Lépine J P. [Antidepressants consumption in the global population in France]. Encephale 2002;28;411–17 (in French).
van Marwijk H W, Bijl D, Adegrave HJ, de Haan M. Antidepressant prescription for depression in general practice in The Netherlands. Pharm World Sci 2001;23:46–9.
World Health Organisation (WHO). WHO Collaborating Center for Drug Statistics Methodology. ATC/DDD Index 2018. Available from: https://www.whocc.no/atc_ddd_index/ (accessed December 5, 2018).
Organisation for Economic Co-operation and Development (OECD). Health policies and data. Health at a Glance: Europe 2014. Available from: https://www.oecd.org/els/health-systems/Health-at-a-Glance-Europe-2014-CHARTSET.pdf (accessed December 5, 2018).
The World Bank. Population, total. Available from: https://data. worldbank.org/indicator/SP.POP.TOTL?locations=IR (accessed December 5, 2018).
Bauer M, Monz BU, Montejo AL, Quail D, Dantchev N, Demyttenaere K, et al. Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 2008;23;66–73.
Stephenson CP, Karanges E, McGregor IS. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry 2013;47;74–87.
Marcus SC, Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry 2010;67;1265–73.
Ilyas S, Moncrieff J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010. Br J Psychiatry 2012;200;393–8.
Ufer M, Meyer SA, Junge O, Selke G, Volz HP, Hedderich J, et al. Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 2007;16;1153–60.
Fegert JM, Kölch M, Zito JM, Glaeske G, Janhsen K. Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 2006;16;197–206.
Azami-Aghdash S, Mohseni M, Etemadi M, Royani S, Moosavi A, Nakhaee M. Prevalence and cause of self-medication in Iran: a systematic review and meta-analysis article. Iran J Public Health 2015;44;1580–93.
Soleymani F, Valadkhani M, Dinarvand R. Challenges and achievements of promoting rational use of drugs in Iran. Iran J Public Health 2009;38;166–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
About this article
Cite this article
Soleymani, F., Taheri, F., Roughead, E. et al. Pattern of Antidepressant Utilization and Cost in Iran from 2006 to 2013 in Comparison with Other Countries. J Epidemiol Glob Health 8, 213–219 (2018). https://doi.org/10.2991/j.jegh.2018.06.101
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2991/j.jegh.2018.06.101